## Abstract A comparative study of the performance of solid and liquid nonβaqueous phases (NAPs) to enhance the mass transfer and biodegradation of hexane by __Pseudomonas aeruginosa__ in twoβphase partitioning bioreactors (TPPBs) was undertaken. A preliminary NAP screening was thus carried out amo
Comparing two prevalence rates in a two-phase design study
β Scribed by Xiao-Hua Zhou; Pete Castelluccio; Siu L. Hui; Cynthia A. Rodenberg
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 120 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0277-6715
No coin nor oath required. For personal study only.
β¦ Synopsis
An epidemiological study often uses a two-phase design to estimate the prevalence rate of a mental disease. In a two-phase design study, the first phase assesses a large sample with an inexpensive screening test, and then the second phase selects a subsample for a more expensive diagnostic evaluation. Furthermore, disease status may not be ascertained for all subjects who are selected for disease verification because some subjects are unable to be clinically assessed, while others may refuse. Since not all screened subjects are selected for diagnostic assessments, there is potential for verification bias. In this paper, we propose the maximum likelihood (ML) and bootstrap methods to correct for verification bias for estimating and comparing the prevalence rates under the missing-at-random (MAR) assumption for the verification mechanism. We also propose a method to test this MAR assumption. Finally, we apply our methods to a large-scale prevalence study of dementia disorders.
π SIMILAR VOLUMES
Often the statistician is faced with the necessity of analysing axb-contingency tables which are partially very sparsely occupied beyond a very-well occupied "kernel". The weak part shallnot be due t o misclaseification or miscalculation. By the aid of a fictive example an analysing strategy is disc
## Abstract Whole cell pyruvate decarboxylase (PDC) from __Candida utilis__ enhanced the enzymatic production of (__R__)βphenylacetylcarbinol (PAC) in an aqueous/octanol biotransformation compared to the partially purified PDC especially for a lower range of initial activities (0.3β2.5 U/mL). With